Selenocystine-Derived Label-Free Fluorescent Schiff Base Nanocomplex for siRNA Delivery Synergistically Kills Cancer Cells

Chemo and siRNA synergic treatments for tumors is a promising new therapeutic trend. Selenocystine, a selenium analog of cysteine, has been considered a potential antitumor agent due to its redox perturbing role. In this study, we developed a nanocarrier for siRNA based on a selenocystine analog eng...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Yang, Haoying, Liu, Qian, Pan, Mingming, Wang, Danli, Pan, Shiyuan, Zhang, Weiran, Wei, Jinfeng, Zhao, Xiaowei, Ji, Junfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878402/
https://www.ncbi.nlm.nih.gov/pubmed/35209090
http://dx.doi.org/10.3390/molecules27041302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878402/
https://www.ncbi.nlm.nih.gov/pubmed/35209090
http://dx.doi.org/10.3390/molecules27041302

Ejemplares similares